---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000056"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T15:17:01.744039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Lifecore changes executive incentive from cash to stock for FY2024

## Summary
- CFO John D. Morberg and James G. Hall will receive FY2024 incentive in fully vested, unrestricted shares instead of cash.
- Number of Bonus Shares equals cash incentive amount divided by fair market value on determination date.
- Shares issued under 2019 Stock Incentive Plan; if insufficient reserves, pro rata issuance with contingent shareholder approval.

## SEC filing metadata
- accession: 0001005286-24-000056
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/0001005286-24-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/lndc-20240501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000056
- JSON: https://secwatch.observer/filing/0001005286-24-000056.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.